Showing results (81-90 of 158) with videos related to
Sort By:
Pageof 16
Plos One|August 17, 2022
Long-term effect of a GnRH-based immunocontraceptive on feral cattle in Hong KongRebecca Pinkham, Ka-Kei Koon, Jason To, et al.Nature Communications|September 23, 2020
Half of resources in threatened species conservation plans are allocated to research and monitoringRachel T Buxton, Stephanie Avery-Gomm, Hsein-Yung Lin, et al.Communications Chemistry|October 19, 2024
Discovery of Trypanosoma brucei inhibitors enabled by a unified synthesis of diverse sulfonyl fluoridesBrian S Mantilla, Jack S White, William R T Mosedale, et al.Research Integrity and Peer Review|February 16, 2021
Re-evaluation of solutions to the problem of unprofessionalism in peer reviewTravis G Gerwing, Alyssa M Allen Gerwing, Chi-Yeung Choi, et al.Journal of the American Geriatrics Society|March 23, 2018
Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance DataHeidi Taipale, Willy Gomm, Karl Broich, et al.Heliyon|April 24, 2020
Effect of vaccination with a novel GnRH-based immunocontraceptive on immune responses and fertility in ratsG Massei, D Cowan, D Eckery, et al.British Journal of Cancer|January 1, 1997
Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significanceC Yiangou, J J Gomm, R C Coope, et al.Research Integrity and Peer Review|August 8, 2020
Quantifying professionalism in peer reviewTravis G Gerwing, Alyssa M Allen Gerwing, Stephanie Avery-Gomm, et al.Scientific Reports|February 22, 2017
Pan-neurexin perturbation results in compromised synapse stability and a reduction in readily releasable synaptic vesicle pool sizeDylan P Quinn, Annette Kolar, Michael Wigerius, et al.British Journal of Cancer|December 1, 1995
Expression of fibroblast growth factor 1 is lower in breast cancer than in the normal human breastG S Bansal, C Yiangou, R C Coope, et al.Pageof 16